These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4015884)

  • 1. Systemic adverse effects of topical ophthalmological drugs: a clinical pharmacologist's view.
    Eckert GM
    Aust N Z J Ophthalmol; 1985 Feb; 13(1):81-4. PubMed ID: 4015884
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of new drugs: a clinical pharmacologist's view.
    Breckenridge AM
    Br Med J; 1980 May; 280(6227):1303-5. PubMed ID: 6992929
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of psychotropic drugs: the clinical pharmacologist's view.
    Herxheimer A
    Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):102-3. PubMed ID: 788741
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic toxicity. Associated with topical ophthalmic medications.
    Flach AJ
    J Fla Med Assoc; 1994 Apr; 81(4):256-60. PubMed ID: 8046365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular and systemic adverse effects of ophthalmic and non ophthalmic medications.
    Izazola-Conde C; Zamora-de la Cruz D; Tenorio-Guajardo G
    Proc West Pharmacol Soc; 2011; 54():69-72. PubMed ID: 22423585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of some ophthalmic medications on pupil size: a literature review.
    Novitskaya ES; Dean SJ; Moore JE; Moore TC; Nagendran S; Sharma A
    Can J Ophthalmol; 2009 Apr; 44(2):193-7. PubMed ID: 19491955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic effects of topical ophthalmic medications.
    Selvin BL
    South Med J; 1983 Mar; 76(3):349-58. PubMed ID: 6131541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New aspects on systemic adverse effects of ocular drugs].
    Uusitalo H; Salminen L
    Duodecim; 1998; 114(3):287-92. PubMed ID: 10895504
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systemic side effects of topical ophthalmic drugs].
    Bodd E; Lunde PK
    Tidsskr Nor Laegeforen; 1990 Apr; 110(11):1375. PubMed ID: 2339383
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse systemic effects from topical eye drugs.
    Med Lett Drugs Ther; 1973 Mar; 15(5):23-4. PubMed ID: 4697471
    [No Abstract]   [Full Text] [Related]  

  • 11. [Type IV allergy to components of ophthalmologic drugs].
    Riedl B; Reitmeier G; Heese A; Hahn H; Peters KP; Hornstein OP
    Klin Monbl Augenheilkd; 1991 Apr; 198(4):251-4. PubMed ID: 1830627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse systemic effects from ophthalmic drugs.
    Med Lett Drugs Ther; 1982 May; 24(610):53-4. PubMed ID: 7078521
    [No Abstract]   [Full Text] [Related]  

  • 13. The unwanted ocular effects from topical ophthalmic drugs. Their occurrence, avoidance and reversal.
    Lyle WM; Hopkins GA
    J Am Optom Assoc; 1977 Dec; 48(12):1519-23. PubMed ID: 599247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of scientific models on clinical psychopharmacology: a pharmacologist's view.
    Lasagna L
    Semin Psychiatry; 1972 Aug; 4(3):271-82. PubMed ID: 4680225
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of systemic toxicity from topical ophthalmic chloramphenicol.
    Phillips CI
    Scott Med J; 2008 Aug; 53(3):54-5. PubMed ID: 18780528
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.
    Gaynes BI; Fiscella R
    Drug Saf; 2002; 25(4):233-50. PubMed ID: 11994027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second place winner. Absorption of topical ophthalmic medications presenting as lethargy and apnea in an infant.
    Kwon KT; Kazzi AA
    J Emerg Med; 2002 Nov; 23(4):371-4. PubMed ID: 12480017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination and application of the permitted daily exposure (PDE) for topical ocular drugs in multipurpose manufacturing facilities.
    Lovsin Barle E; Bizec JC; Glogovac M; Gromek K; Winkler GC
    Pharm Dev Technol; 2018 Mar; 23(3):225-230. PubMed ID: 28361586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse external ocular effects of topical ophthalmic medications.
    Wilson FM
    Surv Ophthalmol; 1979; 24(2):57-88. PubMed ID: 390752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmaco-toxicological aspects of ophthalmological medication].
    Cristea E
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1985; 29(2):135-40. PubMed ID: 3161128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.